Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Average PDC per NOAC

From: NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands

PDCa Apixaban Dabigatran Rivaroxaban
Mean 109 108 113 81 141 120
Median 102 101 103
  1. a All patients with more than 1 dispensing
  2. Excluding patients with weekly dispensings